Normal interleukin-7 (IL7) levels and normal IL7 response to CD4 T lymphopenia in patients with multiple sclerosis and systemic sclerosis

Clinical Immunology

Volumn 121, Issue 1, 2006, Pages 118-119

  Storek, Jan ^a,b   Nash, Richard A ^a   McSweeney, Peter A ^c   Furst, Daniel E ^d   Sullivan, Keith M ^e  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c Rocky Mountain Cancer Center   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 7; THYMOCYTE ANTIBODY;

ADULT; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SYSTEMIC SCLEROSIS; WHOLE BODY RADIATION;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; INTERLEUKIN-7; LYMPHOPENIA; MIDDLE AGED; MULTIPLE SCLEROSIS; SCLERODERMA, SYSTEMIC;

EID: 33748602104     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2006.05.016     Document Type: Letter

References (9)

1. Fry T.J., and Mackall C.L. Interleukin-7: from bench to clinic. Blood 99 (2002) 3892-3904
2. Ponchel F., Verburg R.J., Bingham S.J., et al. Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia. Arthritis Res. Ther. 7 (2005) R80-R92
3. Issacs J.D., Greer S., Sharma S., et al. Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia. Arthritis Rheum. 44 (2001) 1998-2008
4. Moore J., Brooks P., Milliken S., et al. A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis Rheum. 46 (2002) 2301-2309
5. Verburg R.J., Flierman R., Sont J.K., et al. Outcome of intensive immunosuppression and autologous stem cell transplantation in patients with severe rheumatoid arthritis is associated with the composition of synovial T cell infiltration. Ann. Rheum. Dis. 64 (2005) 1397-1405
6. Storek J., Zhao Z., Lin E., et al. Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases). Clin. Immunol. 113 (2004) 285-298
7. Farge D., Henegar C., Carmagnat M., et al. Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis. Arthritis Rheum. 52 (2005) 1555-1563
8. Muraro P.A., Douek D.C., Packer A., et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J. Exp. Med. 201 (2005) 805-816
9. Cox A.L., Thompson S.A., Jones J.L., et al. Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis. Eur. J. Immunol. 35 (2005) 3332-3342